Sponsored

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.

Watch a webinar as experts on gastrointestinal stromal tumors (GIST) discuss the intricacies of advanced GIST, and the INVICTUS clinical study.

When Bob was first diagnosed and treated for follicular lymphoma, he refused to let the fear of the cancer returning dominate his life. Nearly 25 years later—after having experienced a relapse—Bob is still in remission and chooses to live his life to the fullest and celebrate life’s joys every day.

This episode of the Cancer Horizons podcast features genitourinary oncologist Ulka Vaishampayan, MBBS, and is sponsored by Bristol Myers Squibb.

A new survey from HealthTree Foundation and Adaptive Biotechnologies shows that patients with multiple myeloma report significant clinical and emotional benefits from MRD testing and 90% of patients who have had MRD testing would recommend it to others, underscoring its benefits and providing support for broad clinical use.

Sponsored by AbbVie

This article is sponsored by AstraZeneca and Merck.

A Navy veteran and football coach tackles prostate cancer diagnosis, with family’s support.

Dr. Eunice Wang shares the importance of staying informed about AML subtypes and genetic mutations like FMS-like tyrosine kinase 3 (FLT3), getting tested and engaging your caregiver team

Sponsored Content by Daiichi Sankyo

Relapsed/refractory diffuse large B-cell lymphoma (DLBCL) cancer survivor Louise (left) and her oncologist, Dr. Ruemu Birhiray (right), built a lasting relationship as they navigated Louise’s diagnosis and relapse. This article is sponsored by MorphoSys and Incyte.

Sponsored by Incyte

This article is sponsored Astellas Pharma US, Inc.

This article is sponsored by Aadi Bioscience, Inc.

City of Hope sets the bar for treating people, not just diseases.